Patients with HFE (“high-Fe”) gene mutations that cause hemochromatosis may be at increased risk [14], but, at present, even the scarce genetic analysis performed on thalassemia patients in Pakistan and elsewhere generally is limited to mutations in the HBB gene, and does not routinely include mutations in the HFE gene. This evidence concerns the gene HBB and hemochromatosis.